Cremolini, C., Antoniotti, C., Lonardi, S., Aprile, G., Bergamo, F., Masi, G., . . . Falcone, A. (2018). Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial. JAMA Oncol.
Citação norma ChicagoCremolini, Chiara, et al. "Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed By Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial." JAMA Oncol 2018.
Deismireacht MLACremolini, Chiara, et al. "Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed By Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial." JAMA Oncol 2018.